NCT06487624 2026-02-05
An Engineered Sirpα Fused to Anti-Pd-L1 And Tgf-β Fusion Protein (HCB301) in Subjects With Selected Advanced Tumors
FBD Biologics Limited
Phase 1 Recruiting
Clinical Trials
3 trialsNCT02065362 2026-01-29
TGF-beta Resistant Cytotoxic T-lymphocytes in Treatment of EBV-positive Nasopharyngeal Carcinoma / RESIST-NPC
Baylor College of Medicine
Phase 1 Active not recruiting
NCT02937272 2025-10-20
A Study of LY3200882 in Participants With Solid Tumors
Eli Lilly and Company
Phase 1 Active not recruiting